Navigation Links
Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
Date:3/31/2009

PRINCETON, N.J., March 31 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) announced today that dosing has started in a phase 1, single ascending dose (SAD) study in healthy volunteers with PSI-7851, a second generation nucleotide analog polymerase inhibitor of hepatitis C virus (HCV). Pharmasset filed an Investigational New Drug Application (IND) with the Food and Drug Administration (FDA) earlier this quarter.

"This is a significant milestone for Pharmasset. PSI-7851 is a wholly owned, second generation nucleotide analog that was discovered by Pharmasset scientists" stated Dr. Michelle Berrey, Pharmasset's Chief Medical Officer. "We continue to see nucleos(t)ide inhibitors as having the potential to be the cornerstone of future HCV treatment, given their higher barrier to resistance and antiviral activity across multiple HCV genotypes, characteristics that set them apart from other HCV drug classes. We look forward to reporting the first antiviral data with PSI-7851 in the second half of 2009."

About PSI-7851

PSI-7851 is a uridine nucleoside analog currently in developed for the treatment of chronic HCV infection. PSI-7851 has demonstrated in vitro anti-HCV activity with EC(50) values of 90 +/- 60 nM, which is approximately 15- to 20-fold more potent than the active metabolite of Pharmasset's first generation nucleoside polymerase inhibitor, R7128. In vitro studies of PSI-7851 have not shown evidence of any mitochondrial or other cellular toxicities that may be associated with some nucleoside analogs. The half-life of the triphosphate in primary human hepatocytes is approximately 38 hours, which suggests the possibility for once-daily dosing. Like R7128, PSI-7851 has demonstrated in vitro activity against all of the most common HCV genotypes.

About Pharmasset'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmasset Reports Fiscal Year End 2008 Financial Results
2. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
3. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
4. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
5. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
6. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
7. Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
8. Pharmasset Receives Notice of Allowance
9. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
10. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
11. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... 2014 ... has announced the addition of the  ... Automated External Defibrillators (AED) Market"  report ... ,The report North American Automated External ... of devices based upon following sub-segments ...
(Date:10/17/2014)... Oct. 17, 2014  Talyst, a market leader in ... Annual Meeting in Nashville, TN. ... market leading solution for onsite, remote medication dispensing. ... facilities to safely and securely dispense medication onsite, on ... dose, helps ensure that the correct medication gets to ...
(Date:10/17/2014)... -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" ... biopharmaceutical company in China , ... from the China Food and Drug Administration (the ... concentrate ("PCC") at its Shandong Taibang facility. The ... facility for Good Manufacturing Practices ("GMP") compliance in ...
Breaking Medicine Technology:Micro Market Monitor : North American Automated External Defibrillators (AED) Market 2Talyst Exhibits at LeadingAge Annual Meeting 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 3
... 14, 2011 Micross Components, a leading global ... as General Manager of its US Products & ... product and business development, will play a leading ... its offerings to increase market share across several ...
... YORK and JERUSALEM, Sept. 14, 2011 Chiasma, Inc., a ... & CEO, will present an overview of the Company at ... New York, New York, on Monday, September 19, 2011 at ... an oral form of octreotide acetate being developed first for ...
Cached Medicine Technology:Micross Components Names Mike Deley as General Manager of US Products & Services Division 2Chiasma to Present at the UBS Global Life Sciences Conference 2
(Date:10/20/2014)... California (PRWEB) October 20, 2014 Final Cut ... the release of the Citrus theme for FCPX filmmakers ... would use to describe the Citrus theme” Says Christina Austin, ... easy to look so professional.” , Citrus comes with all ... with the template are: four transitions for added style, a ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Houston plastic ... present the key elements of his innovative True ... to plastic surgery residents and faculty at The ... where he, too, was once a medical student. Patronella, ... largest private cosmetic plastic surgery practices in Texas, ...
(Date:10/19/2014)... 20, 2014 Recently, BambooIndustry.com, one of ... its new range of bamboo deckings . Moreover, ... natural items; they are now available at deeply discounted ... it is hard to overstate the significance of online ... to online services. The company’s workers are striving to ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 Recently, ... and announced that JustHost, GoDaddy and HostMonster are ... market. VPS (Virtual Private Server) is the method ... servers, each of which has the appearance and ... That is why the site pays close attention ...
(Date:10/19/2014)... 2014 Stephen T. Greenberg, M.D., with offices ... the 10th consecutive year as one of Long Island’s best ... also been nominated as the best provider for Botox injections. ... best Day Spa and best Laser Treatment center on Long ... readers can vote for the contest once per day, per ...
Breaking Medicine News(10 mins):Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Dr. Stephen T. Greenberg – Nominated for the 10th Consecutive Year for One of Long Island’s Best Cosmetic Surgeons for 2015 by the Long Island Press 2
... American Society of Hypertension, Inc. (ASH) today announced the ... related cardiovascular disease -- the ASH Hypertension Accreditation Program ... health professionals and pharmaceutical sales representatives. While this rigorous ... needs of each of the intended target groups, it ...
... 22 Medifast, Inc. (NYSE: MED ) announced today ... for the period ended March 31, 2009 on Wednesday, April 29, ... hold a conference call and web cast to discuss the results ... access the call by dialing (877) 407-0782 or (201) 689-8567, or ...
... little evidence for transfusions improving healthMILWAUKEE, Wis., April 22 ... literature by a panel of experts at the International ... (ICCTO) held this month in Phoenix concluded that ... from the greatest number of transfusions currently being given ...
... AcelRx Pharmaceuticals, Inc. today announced that it ... ARX-02, a proprietary sublingual sufentanil NanoTab(TM) product candidate ... of this multicenter, randomized, placebo-controlled, crossover study is ... relative to placebo in cancer patients experiencing episodic ...
... American Fertility Association,s Infertility Prevention ProgramNEW YORK, April 22 ... have difficulty conceiving, but many of those cases could ... changes. Education is the key and what better way ... infertility robs women of control over their own lives. ...
... Holly of the California Superior Court for San Joaquin County certified a ... Viking Industries. , ... Los Angeles, California (Lexis Nexis) April 22, 2009 ... the California Superior Court for San Joaquin County certified a Class ...
Cached Medicine News:Health News:The American Society of Hypertension Launches Education Program for Hypertension Accreditation 2Health News:The American Society of Hypertension Launches Education Program for Hypertension Accreditation 3Health News:The American Society of Hypertension Launches Education Program for Hypertension Accreditation 4Health News:Medifast, Inc. to Announce First Quarter Fiscal Year 2009 Financial Results on Wednesday, April 29, 2009 2Health News:Blood Transfusion and Outcomes 2Health News:Blood Transfusion and Outcomes 3Health News:Blood Transfusion and Outcomes 4Health News:AcelRx Announces Initiation of Phase 2 Cancer Breakthrough Pain Program 2Health News:Free Manicures & Martinis Hits Chicago and Denver 2Health News:Free Manicures & Martinis Hits Chicago and Denver 3Health News:Eppsteiner and Fiorica and Milstein, Adelman & Kreger Report Lawsuit Certified as Class Action Against Pella Subidiary, Viking Industries 2
... All-in-one procedure drape made of 3M™ Steri-Drape™ ... to create a sterile field during procedures ... quick and convenient by eliminating the need ... of extremity drapes with elastic apertures suitable ...
The Abbott Commander is an automated, high-throughput immunoassay testing system. The Commander System consists of the Flexible Pipetting Center, the Parallel Processing Center, and the Dynamic Incub...
... Abbott m1000 sample preparation platform is an ... and DNA from patient samples using novel ... fully automated sample preparation and is cabable ... hours for a 1 ml sample volume., ...
... CELL-DYN 3700 combines optical light scatter ... Scatter Separation (MAPSS) to fully automate ... improve performance and productivity in critical-care ... revolutionary concept of complementary technologies to ...
Medicine Products: